» Articles » PMID: 28151767

Increasing Incidence and Altered Presentation in a Population-based Study of Pediatric Celiac Disease in North America

Overview
Publisher Wiley
Date 2017 Feb 3
PMID 28151767
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Celiac disease (CD) is a common immune-mediated disorder that affects up to 1% of the general population. Recent reports suggest that the incidence of CD has reached a plateau in many countries. We aim to study the incidence and altered presentation of childhood CD in a well-defined population.

Methods: Using the Rochester Epidemiology Project, we retrospectively reviewed Mayo Clinic and Olmsted Medical Center medical records from January 1994 to December 2014. We identified all CD cases of patients ages 18 years or younger at the time of diagnosis. Incidence rates were calculated by adjusting for age, sex, and calendar year and standardizing to the 2010 US white population.

Results: We identified 100 patients with CD. Incidence of CD has increased from 8.1 per 100,000 person-years (2000-2002) to 21.5 per 100,000 person-years (2011-2014). There was an increase in CD prevalence in children from 2010 (0.10%) to 2014 (0.17%). Thirty-four patients (34%) presented with classical CD symptoms, 43 (43%) had nonclassical CD, and 23 (23%) were diagnosed by screening asymptomatic high-risk patients. Thirty-six patients (36%) had complete villous atrophy, 51 (51%) had partial atrophy, and 11 (11%) had increased intraepithelial lymphocytes. Two patients were diagnosed without biopsy. Most patients (67%) had a normal body mass index, 17% were overweight/obese, and only 9% were underweight.

Conclusions: Both incidence and prevalence of CD have continued to increase in children during the past 15 years in Olmsted County, Minnesota. Clinical and pathologic presentations of CD are changing over time (more nonclassical and asymptomatic cases are emerging).

Citing Articles

Children who develop celiac disease are predicted to exhibit distinct metabolic pathways among their gut microbiota years before diagnosis.

Kelley K, Dogru D, Huang Q, Yang Y, Palm N, Altindis E Microbiol Spectr. 2025; 13(3):e0146824.

PMID: 39902908 PMC: 11878042. DOI: 10.1128/spectrum.01468-24.


Clinical Presentations of Celiac Disease: Experience of a Single Italian Center.

Trovato C, Ferretti F, Delli Bovi A, Elefante G, Ancinelli M, Bolasco G Nutrients. 2025; 17(1.

PMID: 39796563 PMC: 11723102. DOI: 10.3390/nu17010129.


Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults.

Parks C, Jusko T, Meier H, Wilkerson J, Rider L, Miller F J Autoimmun. 2024; 149():103340.

PMID: 39581147 PMC: 11730459. DOI: 10.1016/j.jaut.2024.103340.


Coeliac Disease in Children-A Clinical Review Including Novel Treatment Agents.

Corlett C, Rodrigues A, Ravikumara M Medicina (Kaunas). 2024; 60(10).

PMID: 39459437 PMC: 11509383. DOI: 10.3390/medicina60101650.


BMI Status of Children with Celiac Disease Has Changed in the Last Decades: A 30-Year Retrospective Study.

Monzani A, Marcolin S, Medina F, Valentino K, Rabbone I Nutrients. 2024; 16(16).

PMID: 39203865 PMC: 11356937. DOI: 10.3390/nu16162729.


References
1.
White L, Merrick V, Bannerman E, Russell R, Basude D, Henderson P . The rising incidence of celiac disease in Scotland. Pediatrics. 2013; 132(4):e924-31. DOI: 10.1542/peds.2013-0932. View

2.
Ji J, Ludvigsson J, Sundquist K, Sundquist J, Hemminki K . Incidence of celiac disease among second-generation immigrants and adoptees from abroad in Sweden: evidence for ethnic differences in susceptibility. Scand J Gastroenterol. 2011; 46(7-8):844-8. DOI: 10.3109/00365521.2011.579999. View

3.
Rubio-Tapia A, Hill I, Kelly C, Calderwood A, Murray J . ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013; 108(5):656-76. PMC: 3706994. DOI: 10.1038/ajg.2013.79. View

4.
Ravikumara M, Tuthill D, Jenkins H . The changing clinical presentation of coeliac disease. Arch Dis Child. 2006; 91(12):969-71. PMC: 2083005. DOI: 10.1136/adc.2006.094045. View

5.
Sugai E, Vazquez H, Nachman F, Moreno M, Mazure R, Smecuol E . Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease. Clin Gastroenterol Hepatol. 2006; 4(9):1112-7. DOI: 10.1016/j.cgh.2006.05.004. View